Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 14 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 8394377

    Methods for treating cancer using combination therapy

    The Regents of the University of Colorado · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  2. US 8361471

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  3. US 8337830

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  4. US 8329753

    Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition

    The Regents of the University of Colorado · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  5. US 8318490

    Prelamin A pre peptide as a universal stem cell differentiation signal

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  6. US 8293275

    Spray freeze dry of compositions for pulmonary administration

    The Regents of the University of Colorado · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  7. US 8293240

    Method of treating drug-resistant cancer

    The Regents of the University of Colorado · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  8. US 8282963

    Methods for extracting platelets and compositions obtained therefrom

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  9. US 8252737

    Antimicrobial peptides and methods of use

    The Regents of the University of Colorado · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  10. US 8221763

    Yeast-antigen compositions and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  11. US 8222392

    Kit for detection of telomerase reverse transcriptase nucleic acids

    The Regents of the University of Colorado · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  12. US 8168415

    Axl fusion proteins as Axl tyrosine kinase inhibitors

    The Regents of the University of Colorado · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

  13. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  14. US 8153136

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  15. US 8137672

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted

  16. US 8138312

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted

  17. US 8093286

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  18. US 8080578

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  19. US 8076304

    Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions

    The Regents of the University of Colorado · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  20. US 8071645

    Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors

    The Regents of the University of Colorado · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  21. US 8062643

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  22. US 8057807

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  23. US 8039001

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  24. US 8017321

    Gefitinib sensitivity-related gene expression and products and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.